{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:47:13Z","timestamp":1767890833891,"version":"3.49.0"},"reference-count":45,"publisher":"Japan Endocrine Society","issue":"6","funder":[{"name":"Ehime University Research Unit System"},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17K08985"],"award-info":[{"award-number":["JP17K08985"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej25-0033","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T22:14:15Z","timestamp":1741817655000},"page":"727-741","source":"Crossref","is-referenced-by-count":1,"title":["The influence of hypertensive disorders of pregnancy on the development of long-term postpartum type 2 diabetes mellitus"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0794-6648","authenticated-orcid":false,"given":"Shota","family":"Inoue","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6530-4078","authenticated-orcid":false,"given":"Yasunori","family":"Takata","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Molecular Genetics, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4505-7951","authenticated-orcid":false,"given":"Yasuharu","family":"Tabara","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"},{"name":"Graduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka 420-0881, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7862-7693","authenticated-orcid":false,"given":"Koutatsu","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Bioscience, Graduate School of Agriculture, Ehime University, Ehime 790-8566, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0289-8363","authenticated-orcid":false,"given":"Haruhiko","family":"Osawa","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Molecular Genetics, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3715-0075","authenticated-orcid":false,"given":"Takashi","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Umesawa M, Kobashi G (2017) Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res 40: 213\u2013220.","DOI":"10.1038\/hr.2016.126"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2  (2020) Gestational hypertension and preeclampsia: ACOG practice bulletin summary, number 222. Obstet Gynecol 135: 1492\u20131495.","DOI":"10.1097\/AOG.0000000000003892"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Bellamy L, Casas JP, Hingorani AD, Williams DJ (2007) Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335: 974.","DOI":"10.1136\/bmj.39335.385301.BE"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ (2008) Cardiovascular sequelae of preeclampsia\/eclampsia: a systematic review and meta-analyses. Am Heart J 156: 918\u2013930.","DOI":"10.1016\/j.ahj.2008.06.042"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Sattar N, Greer IA (2002) Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 325: 157\u2013160.","DOI":"10.1136\/bmj.325.7356.157"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6 Kurabayashi T, Mizunuma H, Kubota T, Kiyohara Y, Nagai K, et al. (2013) Pregnancy-induced hypertension is associated with maternal history and a risk of cardiovascular disease in later life: Japanese cross-sectional study. Maturitas 75: 227\u2013231.","DOI":"10.1016\/j.maturitas.2013.04.002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, et al. (2009) Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 53: 944\u2013951.","DOI":"10.1161\/HYPERTENSIONAHA.109.130765"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Feig DS, Shah BR, Lipscombe LL, Wu CF, Ray JG, et al. (2013) Preeclampsia as a risk factor for diabetes: a population-based cohort study. PLoS Med 10: e1001425.","DOI":"10.1371\/journal.pmed.1001425"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 M\u00e4nnist\u00f6 T, Mendola P, V\u00e4\u00e4r\u00e4sm\u00e4ki M, J\u00e4rvelin MR, Hartikainen AL, et al. (2013) Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation 127: 681\u2013690.","DOI":"10.1161\/CIRCULATIONAHA.112.128751"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10 Libby G, Murphy DJ, McEwan NF, Greene SA, Forsyth JS, et al. (2007) Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort. Diabetologia 50: 523\u2013530.","DOI":"10.1007\/s00125-006-0558-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Savitz DA, Danilack VA, Elston B, Lipkind HS (2014) Pregnancy-induced hypertension and diabetes and the risk of cardiovascular disease, stroke, and diabetes hospitalization in the year following delivery. Am J Epidemiol 180: 41\u201344.","DOI":"10.1093\/aje\/kwu118"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Callaway LK, Lawlor DA, O\u2019Callaghan M, Williams GM, Najman JM, et al. (2007) Diabetes mellitus in the 21 years after a pregnancy that was complicated by hypertension: findings from a prospective cohort study. Am J Obstet Gynecol 197: 492.e491\u2013e497.","DOI":"10.1016\/j.ajog.2007.03.033"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Laivuori H, Tikkanen MJ, Ylikorkala O (1996) Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 81: 2908\u20132911.","DOI":"10.1210\/jcem.81.8.8768850"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Spaan JJ, Houben AJ, Musella A, Ekhart T, Spaanderman ME, et al. (2010) Insulin resistance relates to microvascular reactivity 23 years after preeclampsia. Microvasc Res 80: 417\u2013421.","DOI":"10.1016\/j.mvr.2010.07.003"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15 McDonald SD, Ray J, Teo K, Jung H, Salehian O, et al. (2013) Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia. Atherosclerosis 229: 234\u2013239.","DOI":"10.1016\/j.atherosclerosis.2013.04.020"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Alsnes IV, Janszky I, Forman MR, Vatten LJ, \u00d8kland I (2014) A population-based study of associations between preeclampsia and later cardiovascular risk factors. Am J Obstet Gynecol 211: 657.e651\u2013e657.","DOI":"10.1016\/j.ajog.2014.06.026"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Kido Y (2017) Gene-environment interaction in type 2 diabetes. Diabetol Int 8: 7\u201313.","DOI":"10.1007\/s13340-016-0299-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Griffin S (2022) Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time. Diabetologia 65: 1913\u20131921.","DOI":"10.1007\/s00125-022-05782-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 S\u00f8rensen TIA, Metz S, Kilpel\u00e4inen TO (2022) Do gene-environment interactions have implications for the precision prevention of type 2 diabetes? Diabetologia 65: 1804\u20131813.","DOI":"10.1007\/s00125-021-05639-5"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20 Tabara Y, Osawa H, Kawamoto R, Onuma H, Shimizu I, et al. (2009) Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 58: 493\u2013498.","DOI":"10.2337\/db07-1785"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Tabara Y, Saito I, Nishida W, Kohara K, Sakurai S, et al. (2011) Relatively lower central aortic pressure in patients with impaired insulin sensitivity and resistance: the toon health study. J Hypertens 29: 1948\u20131954.","DOI":"10.1097\/HJH.0b013e32834abd06"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Umemura S, Arima H, Arima S, Asayama K, Dohi Y, et al. (2019) The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res 42: 1235\u20131481.","DOI":"10.1038\/s41440-019-0284-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 American Diabetes Association Professional Practice Committee (2022) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care 45: S17\u2013S38.","DOI":"10.2337\/dc22-S002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, et al. (2024) Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. J Atheroscler Thromb 31: 641\u2013853.","DOI":"10.5551\/jat.GL2022"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25 Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome\u2014a new worldwide definition. Lancet 366: 1059\u20131062.","DOI":"10.1016\/S0140-6736(05)67402-8"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26 Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462\u20131470.","DOI":"10.2337\/diacare.22.9.1462"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Retnakaran R, Qi Y, Goran MI, Hamilton JK (2009) Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 26: 1198\u20131203.","DOI":"10.1111\/j.1464-5491.2009.02841.x"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28 Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M (2007) What is the best predictor of future type 2 diabetes? Diabetes Care 30: 1544\u20131548.","DOI":"10.2337\/dc06-1331"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK, et al. (2008) Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity (Silver Spring) 16: 1901\u20131907.","DOI":"10.1038\/oby.2008.307"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30 Stanc\u00e1kov\u00e1 A, Javorsk\u00fd M, Kuulasmaa T, Haffner SM, Kuusisto J, et al. (2009) Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 58: 1212\u20131221.","DOI":"10.2337\/db08-1607"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 DeFronzo RA, Tripathy D, Abdul-Ghani M, Musi N, Gastaldelli A (2014) The disposition index does not reflect \u03b2-cell function in IGT subjects treated with pioglitazone. J Clin Endocrinol Metab 99: 3774\u20133781.","DOI":"10.1210\/jc.2014-1515"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Dudbridge F (2013) Power and predictive accuracy of polygenic risk scores. PLoS Genet 9: e1003348.","DOI":"10.1371\/journal.pgen.1003348"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 VanderWeele T, Knol M (2014) A tutorial on interaction. Epidemiol Method 3: 33\u201372.","DOI":"10.1515\/em-2013-0005"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Zou GY (2008) On the estimation of additive interaction by use of the four-by-two table and beyond. Am J Epidemiol 168: 212\u2013224.","DOI":"10.1093\/aje\/kwn104"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Imamura M, Shigemizu D, Tsunoda T, Iwata M, Maegawa H, et al. (2013) Assessing the clinical utility of a genetic risk score constructed using 49 susceptibility alleles for type 2 diabetes in a Japanese population. J Clin Endocrinol Metab 98: E1667\u2013E1673.","DOI":"10.1210\/jc.2013-1642"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Ghosh C, Das N, Saha S, Kundu T, Sircar D, et al. (2022) Involvement of Cdkal1 in the etiology of type 2 diabetes mellitus and microvascular diabetic complications: a review. J Diabetes Metab Disord 21: 991\u20131001.","DOI":"10.1007\/s40200-021-00953-6"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Calles-Escandon J, Cipolla M (2001) Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22: 36\u201352.","DOI":"10.1210\/edrv.22.1.0417"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Torkamani A, Wineinger NE, Topol EJ (2018) The personal and clinical utility of polygenic risk scores. Nat Rev Genet 19: 581\u2013590.","DOI":"10.1038\/s41576-018-0018-x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Virolainen SJ, VonHandorf A, Viel K, Weirauch MT, Kottyan LC (2023) Gene-environment interactions and their impact on human health. Genes Immun 24: 1\u201311.","DOI":"10.1038\/s41435-022-00192-6"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Parada-Ni\u00f1o L, Castillo-Le\u00f3n LF, Morel A (2022) Preeclampsia, natural history, genes, and miRNAs associated with the syndrome. J Pregnancy 2022: 3851225.","DOI":"10.1155\/2022\/3851225"},{"key":"41","unstructured":"41 Tuerxunyiming M, Mohemaiti P, Wufuer H, Tuheti A (2015) Association of rs7754840 G\/C polymorphisms in CDKAL1 with type 2 diabetes: a meta-analysis of 70141 subjects. Int J Clin Exp Med 8: 17392\u201317405."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Horikawa Y, Miyake K, Yasuda K, Enya M, Hirota Y, et al. (2008) Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab 93: 3136\u20133141.","DOI":"10.1210\/jc.2008-0452"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Lee YH, Kang ES, Kim SH, Han SJ, Kim CH, et al. (2008) Association between polymorphisms in SLC30A8, HHEX, CDKN2A\/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet 53: 991\u2013998.","DOI":"10.1007\/s10038-008-0341-8"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Stanc\u00e1kov\u00e1 A, Pihlajam\u00e4ki J, Kuusisto J, Stefan N, Fritsche A, et al. (2008) Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance. J Clin Endocrinol Metab 93: 1924\u20131930.","DOI":"10.1210\/jc.2007-2218"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Diehl CL, Brost BC, Hogan MC, Elesber AA, Offord KP, et al. (2008) Preeclampsia as a risk factor for cardiovascular disease later in life: validation of a preeclampsia questionnaire. Am J Obstet Gynecol 198: e11\u2013e13.","DOI":"10.1016\/j.ajog.2007.09.038"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/6\/72_EJ25-0033\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:42:09Z","timestamp":1749271329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/6\/72_EJ25-0033\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0033","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ25-0033"}}